Business

+++ Kopexa +++ 14leafs +++ Taxfix +++ Cellbricks +++

#StartupTicker

+++ #StartupTicker +++ Startup of the week: Kopexa +++ 14leafs from Würzburg invests 50 million in young startups +++ Loss at Taxfix fell 19.5 million (previous year: 48.7 million) +++ StartupsToWatch: Cellbricks +++

+++ Kopexa +++ 14leafs +++ Taxfix +++ Cellbricks +++

What’s up New? In ours #StartupTicker we provide a compact overview of the most important startup news of the day (Tuesday, April 7th).

#STARTUPLAND

STARTUPLAND: Founders. VCs. Visionaries

+++ Our fourth STARTUPLAND Conference will take place on March 10, 2027 at the RheinEnergieStadion in Cologne. A fascinating journey into the startup scene awaits you again – with lectures from successful founders, educational interviews and pitches that inspire. More about STARTUPLAND

#STARTUPTICKER

Kopexa
+++ The young company Kopexa is our startup of the week! Behind the RegTech from Kiel is a “modern GRC platform for medium-sized businesses”. “Kopexa is redefining Governance, Risk & Compliance (GRC) with an intelligent, automated, and streamlined approach. We enable businesses to turn compliance from a burden into a competitive advantage,” says the startup about itself. Kopexa was founded by Benjamin Schatter, Julian Köhn and Steffen Berkner. There are more new startups in our startup radar

Tip: In the Startup Radar newsletter, our premium newsletter about new startups, we introduce exciting new startups once a week. Try it free for 30 days now!

14 leaves
+++ Millions for young teams! 14leafs, a venture capital provider for “technology-driven startups in early phases,” is currently being built in Würzburg. The target volume is 50 million euros. The new donor was initiated by the Julius-Maximilians-Universität Würzburg (JMU), the Sparkasse Mainfranken Würzburg and StellaVent Capital. Among others, Flip4New founder Michael Sauer (exit to Foxway) is behind StellaVent Capital. The 14leafs team initially invests between 100,000 and around 1 million euros (pre-seed phase up to Series A) in startups from the “Life Sciences, Health and Deep and Digital Tech” segments. A total of 40 to 50 investments are planned. The young venture capitalist not only invests in startups from Würzburg and the surrounding area (Lower Franconia and Main Franconia), but also in “national startups with an international perspective”.

Tax fix
+++ Number check! The Berlin tax startup Taxfix will once again be a growing company in 2024. The unicorn’s sales rose to 67.3 million euros – after 55.9 million and 38.5 million in previous years. “Organic growth resulted from a higher number of tax returns submitted by new and existing customers as well as slight price effects due to the increase in the DIFM minimum fee in the fourth quarter. Another significant part of the growth is attributable to inorganic effects, in particular the full-year inclusion of Steuerbot and the first-time consolidation of TaxScouts from the second half of the year,” it says in the annual financial statements. Steuerbot contributed 13.3 million in sales. TaxScouts accounted for 3.8 million. The inflows therefore pay off. Taxfix’s loss fell to 19.5 million – after 48.7 million in the previous year. In total, setting up Taxfix by the end of 2023 already cost around 220 million. The team has already collected around 300 million. For 2025, the company recently expected “sales growth in the high single-digit to low double-digit millions”. The deficits should also continue to decrease. In 2024, Taxfix employed “an average of 303 people (previous year 419)”. The company’s goal is to remain in the black. The money collected so far should be sufficient “until profitability is achieved”. More about Taxfix

Cellbricks
+++ StartupsToWatch: Cellbricks Therapeutics. The startup from Berlin, founded in 2018 by Alexander Leutner, Simon MacKenzie and Tobias Lam, develops and prints “biofabricated, living tissue implants for regenerative medicine”. Initially, the company is “focused on adipose tissue for applications in reconstructive surgery and complex wounds, such as burns and trauma.” The long-term vision is “3D bioprinted, functional human organs.” It sounds a bit like science fiction, but it’s a realistic scenario. The English investor Silicon Roundabout Ventures (SRV), SPRIND, ACT Venture Partners and other financiers recently invested 10 million euros in the company. Around 4 million had already flowed into Cellbricks. More about Cellbrick

What else happened recently? That’s always in the #StartupTicker

Startup jobs: Looking for a new challenge? In ours Job exchange You will find job advertisements from startups and companies.

Photo (above): Bing Image Creator – DALL·E 3

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close

Adblock Detected

kindly turn off ad blocker to browse freely